Correction to Lancet Microbe 2021; published online March 23. https://doi.org/10.1016/S2666-5247(21)00025-2

Published 2021-05-01

Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics

by Simon Schroeder, MSc, Fabian Pott, MSc, Daniela Niemeyer, PhD, Talitha Veith, MPhil, Anja Richter, Doreen Muth, PhD, Christine Goffinet, ProfPhD, Marcel A Müller, PhD, Christian Drosten, ProfPhD
Published 2021-05-01

Convalescent plasma from people vaccinated after COVID-19 infection

by Kamal Abu Jabal, Karine Beiruti Wiegler, Michael Edelstein
Published 2021-05-01

El Salvador's malaria elimination success story

by Vijay Shankar Balakrishnan
Published 2021-05-01

Role of high-risk antibiotic use in incidence of health-care-associated Clostridioides difficile infection in Quebec, Canada: a population-level ecological study

by Elise Fortin, PhD, Daniel J G Thirion, ProfPharmD, Manale Ouakki, MSc, Christophe Garenc, PhD, Cindy Lalancette, PhD, Luc Bergeron, MSc, Danielle Moisan, MD, Jasmin Villeneuve, MD, Yves Longtin, MD, Daniel Bolduc, Charles Frenette, Lise-Andrée Galarneau, Christophe Garenc, Cindy Lalancette, Yves Longtin, Vivian Loo, Muleka Ngenda Muadi, Natasha Parisien, Isabelle Rouleau, Noémie Savard, Josée Vachon, Jasmin Villeneuve
Published 2021-05-01

Long-term effects of early antiretroviral initiation on HIV reservoir markers: a longitudinal analysis of the MERLIN clinical study

by Marta Massanella, PhD, Rachel A Bender Ignacio, MD, Javier R Lama, MD, Amélie Pagliuzza, MSc, Sayan Dasgupta, PhD, Ricardo Alfaro, MS, Jessica Rios, MS, Carmela Ganoza, MD, Delia Pinto-Santini, PhD, Trupti Gilada, MD, Ann Duerr, ProfMD, Nicolas Chomont, PhD
Published 2021-05-01

Tafenoquine for the prevention of Plasmodium vivax malaria relapse

by James A Watson, Narimane Nekkab, Michael White
Published 2021-05-01

No end in sight for the Brazilian COVID-19 crisis

by Talha Burki
Published 2021-05-01

Learning from COVID-19 to reimagine tuberculosis diagnosis

by Morten Ruhwald, Sergio Carmona, Madhukar Pai
Published 2021-05-01

Antimicrobial resistance: plus ça change

by The Lancet Microbe
Published 2021-05-01

Surveillance of SARS-CoV-2 in Zimbabwe shows dominance of variants of concern

by Tapfumanei Mashe, Faustinos Tatenda Takawira, Hlanai Gumbo, Agnes Juru, Charles Nyagupe, Kenneth K Maeka, Sekesai Mtapuri-Zinyowera, Muchaneta Gudza-Mugabe, Leonardo de Oliveira Martins, Justin O'Grady, Robert A Kingsley, Andrew J Page, Raiva Simbi
Published 2021-05-01

Perfect as the enemy of good: tracing transmissions with low-sensitivity tests to mitigate SARS-CoV-2 outbreaks

by Lee Kennedy-Shaffer, PhD, Michael Baym, PhD, William P Hanage, PhD
Published 2021-05-01

SARS-CoV-2: eye protection might be the missing key

by Minas Theodore Coroneo, Peter John Collignon
Published 2021-05-01

Histoplasmosis acquired in Alberta, Canada: an epidemiological and genomic study

by Tanis C Dingle, PhD, Matthew A Croxen, PhD, Sumana Fathima, MPH, Sandy Shokoples, MSc, Ashlesha Sonpar, MD, Lynora Saxinger, MD, Ilan S Schwartz, MD
Published 2021-05-01

Asymptomatic individuals positive for anti-SARS-CoV-2 antibodies negative on molecular swab

by Guido Antonelli, Emanuela Anastasi, Fabrizio Ciprani, Rodolfo J Riveros Cabral, Cristiano Ialongo, Maria R Capobianchi, Ombretta Turriziani, Antonio Angeloni
Published 2021-05-01

Mass testing for COVID-19

by Talha Burki
Published 2020-12-01

Africa's $100-million Pathogen Genomics Initiative

by Munyaradzi Makoni
Published 2020-12-01

In preparation for a COVID-19-influenza double epidemic

by Vijay Shankar Balakrishnan
Published 2020-09-01

England's NIHP: self-sabotage ahead of bumpy months?

by The Lancet Microbe
Published 2020-09-01

“The beginning is the most important part of the work”

by The Lancet Microbe
Published 2020-12-01